Literature DB >> 20670301

Fetoscopic laser coagulation for severe twin-to-twin transfusion syndrome: factors influencing perinatal outcome, learning curve of the procedure and lessons for new centres.

R K Morris1, T J Selman, A Harbidge, W I Martin, M D Kilby.   

Abstract

OBJECTIVE: To evaluate the effects of operator experience on perinatal outcome in a single centre.
DESIGN: Prospective consecutive cohort study.
SETTING: Regional tertiary referral Fetal Medicine Centre in the UK. POPULATION: Pregnant women with monochorionic twin pregnancies complicated by severe twin-to-twin transfusion syndrome (TTTS) (at ≤26 completed weeks of gestatiuon) treated by fetoscopic laser coagulation (FLC) between October 2004 and November 2009.
METHODS: Pregnancy characteristics and outcomes were collected. Logistic regression analysis was employed to determine the effect of a priori defined variables on outcome. MAIN OUTCOME MEASURE: Perinatal survival (survival to 28 days or beyond) for one or more twins.
RESULTS: There were 164 consecutive sets of monochorionic twins. The median gestational age (GA) at FLC was 20.4 weeks (interquartile range 18-22.1 weeks), the median interval from FLC to delivery was 88.5 days (interquartile range 53-101 days) and the median GA at delivery was 33.2 weeks (interquartile range 29.7-34.9 weeks). The overall survival was 62%; perinatal survival of one or more twins was 85%. These outcomes improved after about 61 procedures were performed, and after about 3.4 years of experience. Univariate logistic regression analysis indicated that Quintero stage-IV disease decreased (OR 0.26; 95% CI 0.10-0.69) and prolongation of GA at delivery increased the survival of the twins (OR 1.34; 95% CI 1.12-1.60) (P < 0.01). Increasing experience of the procedure by operator led to a significant increase in perinatal survival (P < 0.01; OR 4.59; 95% CI 1.84-11.44). Multivariate logistic regression analysis indicated that only GA at delivery increased survival overall (OR 1.34; 95% CI 1.12-1.60; P = 0.01).
CONCLUSIONS: These data indicate that both relatively large numbers treated and experience with FLC minimises any adverse outcome in monochorionic pregnancies with severe TTTS.

Entities:  

Mesh:

Year:  2010        PMID: 20670301     DOI: 10.1111/j.1471-0528.2010.02680.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  10 in total

1.  Rapid initiation of fetal therapy services with a system of learner-centred training under proctorship: the National University Hospital (Singapore) experience.

Authors:  Arundhati Gosavi; Pradip D Vijayakumar; Bryan Sw Ng; May-Han Loh; Lay Geok Tan; Nuryanti Johana; Yi Wan Tan; Dedy Sandikin; Lin Lin Su; Tuangsit Wataganara; Arijit Biswas; Mahesh A Choolani; Citra Nz Mattar
Journal:  Singapore Med J       Date:  2016-07-21       Impact factor: 1.858

2.  Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators.

Authors:  Tuangsit Wataganara; Arundhati Gosavi; Katika Nawapun; Pradip D Vijayakumar; Nisarat Phithakwatchara; Mahesh Choolani; Lin Lin Su; Arijit Biswas; Citra N Z Mattar
Journal:  J Vis Exp       Date:  2018-03-21       Impact factor: 1.355

Review 3.  Fetal Treatment 2017: The Evolution of Fetal Therapy Centers - A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFTNet).

Authors:  Anita J Moon-Grady; Ahmet Baschat; Darrell Cass; Mahesh Choolani; Joshua A Copel; Timothy M Crombleholme; Jan Deprest; Stephen P Emery; Mark I Evans; Francois I Luks; Mary E Norton; Greg Ryan; Kuojen Tsao; Ross Welch; Michael Harrison
Journal:  Fetal Diagn Ther       Date:  2017-05-23       Impact factor: 2.587

4.  Mentoring a surgical team towards procedural competence in the early learning curve for selective fetoscopic laser photocoagulation.

Authors:  Lalitha Natarajan; Arundhati T Gosavi; Tuangsit Wataganara; Lin Lin Su; Zubair Amin; Tak Yeung Leung; Mahesh Choolani; Arijit Biswas; Citra Nz Mattar
Journal:  Singapore Med J       Date:  2020-09-21       Impact factor: 3.331

5.  Case report of myometrial window following fetoscopic treatment of twin-twin transfusion syndrome: indications of underlying collagen vascular disease?

Authors:  Michael V Zaretsky; David K Manchester; Henry L Galan; Nicholas J Behrendt; Ahmed I Marwan; Kenneth W Liechty; Timothy M Crombleholme
Journal:  Clin Case Rep       Date:  2017-05-09

6.  Comprehensive Metabolomic Profiling of Cord Blood and Placental Tissue in Surviving Monochorionic Twins Complicated by Twin-Twin Transfusion Syndrome With or Without Fetoscopic Laser Coagulation Surgery: A Retrospective Cohort Study.

Authors:  Tianjiao Liu; Li Wen; Shuai Huang; Ting-Li Han; Lan Zhang; Huijia Fu; Junnan Li; Chao Tong; Hongbo Qi; Richard Saffery; Philip N Baker; Mark D Kilby
Journal:  Front Bioeng Biotechnol       Date:  2022-04-12

7.  A study to assess global availability of fetal surgery for myelomeningocele.

Authors:  Adalina Sacco; Lynn Simpson; Jan Deprest; Anna L David
Journal:  Prenat Diagn       Date:  2018-11-20       Impact factor: 3.242

8.  Maternal complications following open and fetoscopic fetal surgery: A systematic review and meta-analysis.

Authors:  Adalina Sacco; Lennart Van der Veeken; Emma Bagshaw; Catherine Ferguson; Tim Van Mieghem; Anna L David; Jan Deprest
Journal:  Prenat Diagn       Date:  2019-02-27       Impact factor: 3.050

9.  Fetal Survival Immediate after Fetoscopic Laser Ablation in Twin to Twin Transfusion Syndrome.

Authors:  So Yeon Kweon; Seung Mi Lee; Keumran Cho; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun
Journal:  J Korean Med Sci       Date:  2019-01-07       Impact factor: 2.153

10.  Parental attachment and depressive symptoms in pregnancies complicated by twin-twin transfusion syndrome: a cohort study.

Authors:  Fiona L Mackie; Helen Pattison; Jelena Jankovic; R Katie Morris; Mark D Kilby
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-31       Impact factor: 3.007

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.